Status:
UNKNOWN
MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer
Lead Sponsor:
Peking University
Conditions:
Multi-disciplinary Treatment
Eligibility:
All Genders
Brief Summary
This is a prospective, multicenter, non-interventional, controlled clinical study. Evaluate MDT performance and benefit analysis in patients with advanced gastric or colorectal cancer after MDT discus...
Eligibility Criteria
Inclusion
- Histopathological diagnosis of recurrent / metastatic gastric or colorectal cancer.
- Participate in formal MDT discussions at the Research Center.
- MDT decision-making at least two subjects involved in treatment.
- Patient informed consent and signed written consent.
Exclusion
- Early or locally advanced gastric cancer or colorectal cancer.
- Accept informal MDT discussions.
- MDT decisions recommend only a single subject for treatment of patients.
- MDT decisions recommend only palliative patients.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2020
Estimated Enrollment :
484 Patients enrolled
Trial Details
Trial ID
NCT03400657
Start Date
November 1 2017
End Date
June 1 2020
Last Update
January 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Beijing, Beijing Municipality, China, 100142